Introduction: Hemangiopericytomas (HPCs) are rare neoplasms which account for approximately 1% of primary vascular tumors. Case Presentation: We report a 73 years old woman with vague abdominal pain who did not have further significant symptoms and was diagnosed to have retroperitoneal hemangiopericytoma. Discussion: The tumor was initially diagnosed by ultrasound evaluation. MRI showed a lobulated mass at lower lateral quadrant of the abdomen, adjacent to left psoas muscle with small cystic components. Successful surgical resection of the tumor indicated a solitary large encapsulated 10 × 7 × 4 centimeter retroperitoneal multiloculated mass. Subsequent pathologic studies confirmed the tumor to be malignant hemangiopericytoma. The patient is currently well and is evaluated by periodic CT scans.
Pure small cell carcinoma of the prostate (SCPCa) is a very rare condition usually with poor survival after diagnosis. It seems to show different clinical features compared to other prostate cancer subtypes, specifically adenocarcinoma. Here, we present a 74-year-old man early diagnosed with SCPCa treated with a cisplatine and etoposide regimen. There was no metastasis found in imaging studies and bone scan. The patient mostly complained of obstructive symptoms which were relieved after resection. Interestingly, our patient experienced a disease free condition after chemotherapy and no further progression was found. This could implicate the critical role of early diagnosis in the treatment of SCPCa despite its aggressive nature.
Background: Current treatment of choice for locally advanced rectal cancer is neoadjuvant chemoradiotherapy (neo-CRT) followed by surgical resection and adjuvant chemotherapy. Some patients may experience complete pathological response (cPR) after the neoadjuvant treatment. However, the predicting factors are still debated. Methods: In this registry-based retrospective cohort study, 258 patients with locally advanced rectal cancer were included. Patients were categorized into two groups with or without cPR. Logistic regression analysis was recruited to investigate the odds ratio for all independent variables, and those with significant results were included in multivariate regression analysis. Results: Achievement of cPR was 21.3%. The odds ratio of cPR was significantly lower when the tumor distance from the anal verge was>10 centimeters (OR=0.24, P=0.040). Also, the odds of cPR with N1 involvement in comparison with N0 involvement decreased for 0.41 (P=0.043). It was also true for patients with N2 involvement in comparison with N0 involvement (OR=0.31, P=0.031). Higher odds ratio of cPR was observed in patients who underwent surgery in>12 weeks after neo-CRT (OR=2.9, P=0.022). Furthermore, the odds of cPR decreased for 0.9 with increasing in carcinoembryonic antigen (CEA) level (P=0.044). Conclusion: Patients with rectal cancer in clinical stage II or lower, without the involvement of the lymphatic system at diagnosis, and with tumors located in the lower parts of the rectum, with lower levels of CEA, and longer duration between neo-CRT and surgery were more likely to achieve cPR after neo-CRT. With the current knowledge, the "wait and watch policy" is still debated and needs to be defined more precisely by upcoming studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.